Skip to main content
Erschienen in: Clinical Rheumatology 3/2017

28.09.2016 | Brief Report

Inflammatory biomarkers, disease activity index, and self-reported disability may be predictors of chronic arthritis after chikungunya infection: brief report

verfasst von: J. Sepúlveda-Delgado, O. L. Vera-Lastra, K. Trujillo-Murillo, L.M. Canseco-Ávila, R.A. Sánchez-González, O. Gómez-Cruz, A. Lugo-Trampe, I. Fernández-Salas, R. Danis-Lozano, A. Contreras-Contreras, A. Mendoza-Torres, S. Domínguez-Arrevillaga, B.A. Mena-Vela, M. Ocaña-Sibilla, J.C. Ramirez-Valdespino, L.J. Jara

Erschienen in: Clinical Rheumatology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

The chikungunya virus (ChikV) is a reemerging mosquito-borne pathogen that causes disabling chronic arthritis. The relationship between clinical evolution and inflammatory biomarkers in patients with ChikV-induced arthritis has not been fully described. We performed a prospective case series to evaluate the association among joint involvement, self-reported disability, and inflammatory biomarkers. Patients with ChikV infection were followed for 1 year. Joint involvement and self-reported disability were evaluated with disease activity index 28 (DAS-28) and World Health Organization Disablement Assessment Schedule II (WHODAS-II). Interleukin-6 (IL-6), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and rheumatoid factor (RF) were used as biomarkers. Ten patients with mean age 48 ±15.04 years were included. Symptoms at diagnosis were fever, arthralgias, myalgias, rash, arthritis, nausea, vomiting, and back pain. Polyarticular involvement was present in seven cases. At diagnosis, measures were as follows: DAS-28, 5.08±1.11; WHODAS-II score, 72.3±10.3 %; CRP, 5.09±7.23 mg/dL; ESR, 33.5±17.5 mm/h; RF, 64±21.7 IU/mL; and IL-6, 17.6±10.3 pg/mL. Six patients developed subacute and chronic symptoms. During follow-up, DAS-28 index, WHODAS-II score, ESR, and IL-6 were statistically different in patients with subacute and chronic symptoms compared to those who resolved in the acute phase (p < 0.05). DAS-28 index, WHODAS-II score, and IL-6 were related to chronicity of articular symptoms and could be used as predictors of ChikV-induced arthritis.
Literatur
1.
Zurück zum Zitat Schwartz O, Albert ML (2010) Biology and pathogenesis of chikungunya virus. Nature. Rev Microbiol 8:491–500 Schwartz O, Albert ML (2010) Biology and pathogenesis of chikungunya virus. Nature. Rev Microbiol 8:491–500
2.
Zurück zum Zitat Weaver SC, Lecuit M (2015) Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med 37:1231–1239 Weaver SC, Lecuit M (2015) Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med 37:1231–1239
5.
Zurück zum Zitat Manimunda SP, Vijayachari P, Uppoor R et al (2010) Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104:392–399CrossRefPubMed Manimunda SP, Vijayachari P, Uppoor R et al (2010) Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104:392–399CrossRefPubMed
6.
Zurück zum Zitat Chen W, Foo SS, Sims NA et al (2015) Arthritogenic alphaviruses: new insights into arthritis and bone pathology. Trends Microbiol 23:35–43CrossRefPubMed Chen W, Foo SS, Sims NA et al (2015) Arthritogenic alphaviruses: new insights into arthritis and bone pathology. Trends Microbiol 23:35–43CrossRefPubMed
7.
Zurück zum Zitat Chow A, Zhisheng H, Ong E et al (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–157CrossRefPubMedPubMedCentral Chow A, Zhisheng H, Ong E et al (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–157CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Lohachanakul J, Weerawat P, Thannagith M et al (2012) High concentrations of circulating interleukin 6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand. Microbiol Immunol 56:134–138CrossRefPubMed Lohachanakul J, Weerawat P, Thannagith M et al (2012) High concentrations of circulating interleukin 6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand. Microbiol Immunol 56:134–138CrossRefPubMed
10.
Zurück zum Zitat Singh JA, Saag KG, Jr SLB et al (2015) American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care& Research. doi:10.1002/acr.22783 Singh JA, Saag KG, Jr SLB et al (2015) American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care& Research. doi:10.​1002/​acr.​22783
11.
Zurück zum Zitat Chopra A, Anuradha V, Ghorpade R et al (2012) Acute chikungunya (CHIKV) and persistent musculoskeletal pain following the 2006 Indian epidemic: a two year prospective rural community study. Epidemiol Infect 140:842–850CrossRefPubMed Chopra A, Anuradha V, Ghorpade R et al (2012) Acute chikungunya (CHIKV) and persistent musculoskeletal pain following the 2006 Indian epidemic: a two year prospective rural community study. Epidemiol Infect 140:842–850CrossRefPubMed
12.
Zurück zum Zitat Rahim AA, Thekkekara RJ, Bina T, Paul BJ (2016) Disability with persistent pain following an epidemic of chikungunya in rural South India. J Rheumatol 43:440–444CrossRefPubMed Rahim AA, Thekkekara RJ, Bina T, Paul BJ (2016) Disability with persistent pain following an epidemic of chikungunya in rural South India. J Rheumatol 43:440–444CrossRefPubMed
13.
Zurück zum Zitat Arroyo-Ávila M, Vilá LM (2015) Rheumatic manifestations in patients with chikungunya infection. P R Health Sci J 34:71–77PubMed Arroyo-Ávila M, Vilá LM (2015) Rheumatic manifestations in patients with chikungunya infection. P R Health Sci J 34:71–77PubMed
14.
Zurück zum Zitat Rodríguez-Morales AJ, Cardona-Ospina JA, Urbano-Garzón SF, Hurtado-Zapata JS (2016) Prevalence of post-chikungunya chronic inflammatory rheumatism: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). doi:10.1002/acr.22900 Mar 25, [Epub ahead of print] Rodríguez-Morales AJ, Cardona-Ospina JA, Urbano-Garzón SF, Hurtado-Zapata JS (2016) Prevalence of post-chikungunya chronic inflammatory rheumatism: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). doi:10.​1002/​acr.​22900 Mar 25, [Epub ahead of print]
15.
Zurück zum Zitat Hawman DW, Stoermer KA, Montgomery SA et al (2013) Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response. J Virol 87:13878–13888CrossRefPubMedPubMedCentral Hawman DW, Stoermer KA, Montgomery SA et al (2013) Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response. J Virol 87:13878–13888CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Chow A, Her Z, Ong EK et al (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–157CrossRefPubMedPubMedCentral Chow A, Her Z, Ong EK et al (2011) Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 203:149–157CrossRefPubMedPubMedCentral
Metadaten
Titel
Inflammatory biomarkers, disease activity index, and self-reported disability may be predictors of chronic arthritis after chikungunya infection: brief report
verfasst von
J. Sepúlveda-Delgado
O. L. Vera-Lastra
K. Trujillo-Murillo
L.M. Canseco-Ávila
R.A. Sánchez-González
O. Gómez-Cruz
A. Lugo-Trampe
I. Fernández-Salas
R. Danis-Lozano
A. Contreras-Contreras
A. Mendoza-Torres
S. Domínguez-Arrevillaga
B.A. Mena-Vela
M. Ocaña-Sibilla
J.C. Ramirez-Valdespino
L.J. Jara
Publikationsdatum
28.09.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 3/2017
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3419-2

Weitere Artikel der Ausgabe 3/2017

Clinical Rheumatology 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.